latest news releases from the newsroom
INFINITE Software Corporation
California Software Announces JD Edwards Migration Plan to Windows
SAN CLEMENTE, Calif., Dec. 16, 2004 (PRIMEZONE) -- California Software Corporation (Pink Sheets:CSWP), a leader in Legacy Extension, Business Intelligence and loan production software for banks, credit unions and consumer lending institutions and developer of the award-winning BABY, Unibol, and INFINITE product lines, announced today its latest program for migrating iSeries-based JD Edwards applications for customers who own source code.
MLON International Ventures, Inc.
Mellon Exchanges Assets With Pearl Asian Mining
SCOTTSDALE, Ariz., Dec. 16, 2004 (PRIMEZONE) -- Mellon Research, Inc. (Pink Sheets:MLON), the market leader in providing boutique investment banking services to private mid cap companies, today announced that it acquired 3,000,000 shares which is less than 5% of Equity Retirement Distributors Canada Ltd. (ERDTF.PK) from Pearl Asian Mining Industries, Inc. (PRMN.PK) in exchange for 500,000,000 newly issued MLON shares subject to SEC RULE 144.
San Diego Gas & Electric
CPUC Approves Accelerated Construction Of Key Transmission Line
SAN DIEGO, Dec. 16, 2004 (PRIMEZONE) -- The California Public Utilities Commission (CPUC) today approved San Diego Gas & Electric's (SDG&E) proposal to accelerate construction of a key transmission line to try to put it in service by September 2005 -- or sooner, if possible -- to help avert potential electricity supply shortages and reduce energy costs for consumers.
Taro Pharmaceutical Industries Ltd.
Taro USA Receives Approval for Halobetasol Propionate Ointment, 0.05% ANDA
HAWTHORNE, N.Y., Dec. 16, 2004 (PRIMEZONE) -- Taro Pharmaceutical Industries Ltd. (Nasdaq:TARO) reported today that Taro Pharmaceuticals U.S.A., Inc. ("Taro USA"), its U.S. affiliate, has received approval from the U.S. Food and Drug Administration ("FDA") for its Abbreviated New Drug Application ("ANDA") for Halobetasol Propionate Ointment, 0.05% ("halobetasol ointment"). In addition, Taro USA received tentative approval for its ANDA for Gabapentin Oral Solution, 250 mg/5 mL ("gabapentin solution").
Coastal Holdings, Inc.
Coastal Holdings, Inc. to Release Financials Early Next Year
HOUSTON, Dec. 16, 2004 (PRIMEZONE) -- Coastal Holdings, Inc. (Pink Sheets:CSJJ), a leading edge global technology holding company, announced today that it will release financial statements on one of its major investments, Vetdermal Systems Limited, upon receipt of them early next year. Vetdermal's legal department has advised CSJJ Management that the financial statements are being finalized and will be provided to CSJJ early in 2005. CEO Andrea Cortellazzi stated: "We are looking forward to release financials on one of our key holdings. We expect them to be positive and display not only the financial strength of Vetdermal but also of CSJJ as one of their major equity investors."